Foresight Diagnostics

Closed

Ultra-Sensitive Cancer Diagnostic Tests

United States · Founded 2020 · $104.3M raised

Founded
2020
Business Model
B2B
Total Funding
$104.3M
Last Round
$33.0M Extension RoundJul 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.

About

Foresight Diagnostics was founded in 2020 by four Stanford University physicians and scientists who sought to develop high-performing circulating tumor DNA assays by improving limits of detection through innovative techniques and enhanced bioinformatics. Its first product, Foresight CLARITY, uses a proprietary patented phased variant detection method to improve the accuracy of ctDNA tests and minimal residual disease measurement. The company established an automated, scalable CLIA-certified laboratory in Boulder, Colorado, and partners with biopharma and academic researchers. Foresight Diagnostics is now a wholly-owned subsidiary of Natera.

Summary

Foresight Diagnostics is a Biotech company based in United States, founded in 2020. It has raised $104.3M in total across 3 rounds, most recently a $33.0M Extension Round in Jul 2024. Investors include Civilization Ventures, Bluebird Ventures and Foresite Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundJul 2024
$33.0M

Sign up to see all 3 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Foresight Diagnostics on Indexed.vc
<a href="https://indexed.vc/companies/foresight-diagnostics"><img src="https://indexed.vc/api/badge/company/foresight-diagnostics" alt="Foresight Diagnostics on Indexed.vc" width="260" height="76" /></a>